********************************************************************************************** ** ** ** SNPs&GO ** ** Predicting disease associated variation using GO terms ** ** ** ********************************************************************************************** Sequence File: FA5_HUMAN.seq Mutation Prediction RI Probability Method D107H Neutral 4 0.323 PhD-SNP: F[D]=12% F[H]=1% Nali=300 D107H Neutral 5 0.240 PANTHER: F[D]=28% F[H]=5% D107H Neutral 4 0.312 SNPs&GO I387T Disease 7 0.852 PhD-SNP: F[I]=72% F[T]=2% Nali=253 I387T Neutral 4 0.296 PANTHER: F[I]=25% F[T]=3% I387T Disease 7 0.835 SNPs&GO C613R Disease 3 0.658 PhD-SNP: F[C]=5% F[R]=0% Nali=266 C613R Disease 0 0.510 PANTHER: F[C]=32% F[R]=1% C613R Disease 8 0.895 SNPs&GO K858R Neutral 8 0.119 PhD-SNP: F[K]=40% F[R]=27% Nali=14 K858R Unclassified NA NA PANTHER: F[K]=NA F[R]=NA K858R Neutral 9 0.068 SNPs&GO Mutation: WT+POS+NEW WT: Residue in wild-type protein POS: Residue position NEW: New residue after mutation Prediction: Neutral: Neutral variation Disease: Disease associated variation RI: Reliability Index Probability: Disease probability (if >0.5 mutation is predicted Disease) Method: SVM type and data PANTHER: Output of the PANTHER algorithm PhD-SNP: SVM input is the sequence and profile at the mutated position SNPs&GO: SVM input is all the input in PhD-SNP, PANTHER and GO term features F[X]: Frequency of residue X in the sequence profile Nali: Number of aligned sequences in the mutated site ********************************************************************************************** ** ** ** Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. (2009). Functional ** ** annotations improve the predictive score of human disease-related mutations in ** ** proteins. Human Mutation. 30:1237-1244. ** ** ** ** Capriotti E, Altman RB. (2011). Improving the prediction of disease-related vari- ** ** ants using protein three-dimensional structure. BMC Bioinformatics. 12 (Sup.4) S3. ** ** ** **********************************************************************************************